Zimbabwe has rejected a substantial American healthcare agreement valued at $367m (£272m) over five years due to the United States' request for confidential information.
The decision came to light after a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
An official spokesperson has since explained that the United States was requesting genetic material for research and commercial purposes but was unwilling to share the resulting advantages from future vaccines.
"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for further talks to find a deal agreeable to all parties so the country's critical HIV treatment initiative can proceed.
Broader Implications
This rejection follows a similar situation in Kenya, where a court blocked a related deal with the US following legal challenges were raised about the safety of citizens' health data.
After returning to the presidency last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to boost transparency and responsibility.
According to reports, 16 African countries have so far signed similar health pacts, constituting more than $18.3bn in new funding.
Details of the Declined Deal
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration would have delivered extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy via American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its biological resources and data indefinitely, with no corresponding promise of access to any medical innovations – such as new medicines or tests – that might result from that shared data," his statement read.
"Effectively, our country would provide the basic resources for medical research without any assurance that the end products would be available to our people if a new pandemic arise."
Sovereignty and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining structures already established via the international health agency.
Mangwana cited its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.
"This system is designed to guarantee that when a country contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to develop them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome ongoing dialogue with our US partners on how future co-operation could be designed in a way that honours the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that negotiations need to persist given that much of the country's HIV programmes were funded by foreign aid.
"If technical issues arise, including those involving information security or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," it commented.
The halted deal underscores the complex debate between receiving much-needed international aid and safeguarding national sovereignty in an increasingly interconnected world.